ФОРМИРОВАНИЕ ПРИНЦИПОВ ПРАВОВОГО РЕГУЛИРОВАНИЯ РЕДАКТИРОВАНИЯ ГЕНОМА ЗАРОДЫШЕВОЙ ЛИНИИ ЧЕЛОВЕКА[51]

Anastasiya Pestrikova; Yelena Kholopova

doi:10.33184/pravgos-2020.4.31

Authors

Anastasiya Pestrikova Togliatti State University
Yelena Kholopova Immanuel Kant Baltic Federal University

DOI:

https://doi.org/10.33184/pravgos-2020.4.31

Keywords:

GENE EDITING, HUMAN GENOME, GENETIC ENGINEERING, LEGAL REGULATION OF BIOTECHNOLOGIES AND GENETIC ENGINEERING

Abstract

The article substantiates the need to establish legal principles for the use of gene modifications in human embryos and reproductive cells; highlights the problems of genome editing that require understanding by legal science, including at the international and national levels, and do not have a clear solution at the present stage.

Purpose: based on the analysis of the legislation of foreign countries, the need for accessibility and openness to the international community of information on the safety of using technologies for gene editing of human germline, the identification of new forms of scientific activity focused on working with public opinion on the use of genetic technologies is proved.

Methods: methods of comparative legal analysis, formal logic, description, statistical methods, and the method of legal norms interpretation are used.

Results: at the present stage, the main task of the legal community is to develop legal principles for regulating public relations in the field of genetic engineering and biomedical technologies. At the same time, the most important component is the formation of public participation and active involvement of public institutions in the formation of the legal environment for creating a system of legal norms that meet the realities of scientific progress and protect the rights and interests of each person and humanity as a whole.

References

Ishii T. Germ line genome editing in clinics: the approaches, objective and global society. Brief Funct Genomics. 2017. № 16 (1). С. 46-56. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291189.

Elsevier. Gene Editing Research. URL: https://www.elsevier.com/ research-intelligence/campaigns/crispr.

Hendriks S., Giesbertz N.A.A., Bredenoord A.L., Repping S. Reasons for being in favour of or against genome miodification: A survey of the Dutch general public. Human Reproduct Open 2018(3). URL: DOI: 10.1093/hropen/hoy008

Lawton G. Hope for the future // New Scientist. 2018. № 239 (3196). P. 6-7.

Baltimore D., Berg P., Botchan M., Carroll D., R. Charo, Church G., Jacob E.C., Daley G., Doudna J. and Fenner M. A prudent path forward for genomic engineering and germline gene modification // Science. 2015. Vol. 348, iss. 6230. P. 36-38.

Kahn J. The Crispr Quandary // New York Times. 2015. 9 Nov. URL: http://www.nytimes.com/2015/11/15/magazine/the-crispr-quandary.html .

Beriain M., Cano M. Gene editing in human embryos. A comment on the Ethical Issues Involved // The ethics of reproductive, philosophy and medicine / ed. M. Soniewicka. 2018. Vol. 128. P. 173-187.

NIH Director Francis Collins, Statement on NIH Funding of Research Using Gene-editing Technologies in Human Embryos. 2015. 28 Apr. URL: https://www.nih.gov/about-nih/who-we-are/nih-director/statements / statement-nih-funding-research-using-gene-editing-technologies-human-embryos.

Cohen G., Adashi E. The FDA is prohibited from going germline // Science. 2016. Vol. 353, iss. 6299. P. 545-546.

Facher L. Why Democrats Reopened the Debate About Germline Gene Editing // STAT. 2019. 18 June. URL: https://www.STATnews.com/2019/ 06/18/democrats-reopened-debate-about-germline-editing.

Mason R., Devlin H. MPs Vote in Favour of "Three-Person Embryo" Law // Guardian. 2015. 3 Feb. URL: https://www.theguardian.com / science/2015/feb/03/mps-vote-favour-three-person-embryo-law.

Friedmann T. Principles for Human Gene Therapy Studies // Science. 2000. Vol. 287, iss. 5461. P. 2163-2165.

Пестрикова А.А. Формирование этико-правовых способов контроля за научными исследованиями в области развития и использования генетических технологий // Актуальные проблемы российского права. 2020. № 10. С. 157-167.

Araki M, Ishii T. International regulatory landscape and integration of corrective genome editing into in vitro fertilization. URL: https://www . nature.com/articles/s41599-019-0319-5.

Xiang J.K. et all. Addressing challenges in the clinical applications associated with CRISPR/Cas9 technology and ethical questions to prevent its misuse // Protein & Cell. 2017. № 8 (11). P. 791-795.

Regalado A. China's CRISPR twins might have had their brains inadvertently enhanced // MIT Technology Review. 2019. 21 Feb. URL: https://www.technologyreview.com/2019/02/21/137309/the-crispr-twins-had-their-brains-altered .

Boggio A., Romano C., Almqvist J. (eds.) Human Germline Modification and the Right to Science // A Comparative Study of National Laws and Policies. 2020. 29 Aug. P. 309-344.

Adachi E., Cohen G. The Ethics of Heritable Genome Editing: New Considerations in a Controversial Area // JAMA. The Journal of the American Medical Association. 2018. № 320 (24).

Hasson K., Darnovsky M. Gene-edited babies: no one has the moral warrant to go it alone // Guardian. 2018. 27 Nov. URL: https://www.theguardian.com/science/2018/nov/27/gene-edited-babies-no-one-has-moral-warrant-go-it-alone .

Britta C van Beers. Rewriting the human genome? Rewriting human rights law? Human rights, human dignity, and human germline modification in the CRISPR era // Jornal of law and the biosciences. URL: https:// DOI: 10.1093/jlb/Isaa006

Rosemann A., Balen A., Nerlich B. at all. Heritable Genome Editing in a Global Context: National and International Policy Challenges // Hastings Center Report. 2019. № 49 (3). P. 30-42.

Пестрикова А.А. Необходимость формирования международно-правового регулирования биомедицинских и клеточных технологий в связи с глобализацией репродуктивной помощи // Евразийский научный журнал. 2019. № 6. С. 54-57.

Petersen A., Munsie M., Tanner C., MacGregor C. and Brophy J. Stem Cell Tourism and the Political Economy of Hope. L.: Palgrave Macmillan, 2017. 218 p.

Doudna J.A., Charpentier E. The new frontier of genome engineering with CRISPR-Cas9 // Science. 2014. Vol. 346, iss. 6213. P. 1077-1086.

Begley S (2019) Fertility clinics around the world asked "CRISPR babies" scientist for how-to help. STAT. URL: https://www.statnews . com/2019/05/28/fertility-clinics-asked-crispr-babies-scientist-for-how-to-help.